StockData
Omnicell, Inc. logo

Omnicell, Inc. (OMCL) stock

OMCLNasdaqElectronic ComputersFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3036% below fair value
$35.03+0.08 (+0.23%)

Close on Nov 13, 2026Market cap $1.60BP/E 36.1Yield –

Omnicell r&d expenses

Research and development expenses are spending on new products and technology.

Omnicell's R&D Expenses for the twelve months ending Sep 30, 2026 was $86.72M, down 5.9% year over year. For fiscal 2025 it was $88.67M, down 1.9% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $104.97M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.67M-1.9%
FY2024Dec 31, 2024$90.41M-6.9%
FY2023Dec 31, 2023$97.12M-7.5%
FY2022Dec 31, 2022$104.97M+38.6%
FY2021Dec 31, 2021$75.72M+7.9%
FY2020Dec 31, 2020$70.16M+2.2%
FY2019Dec 31, 2019$68.64M+5.9%
FY2018Dec 31, 2018$64.84M-1.8%
FY2017Dec 31, 2017$66.02M+14.2%
FY2016Dec 31, 2016$57.80M+64.4%
FY2015Dec 31, 2015$35.16M+26.5%
FY2014Dec 31, 2014$27.80M-4.5%
FY2013Dec 31, 2013$29.11M+22.7%
FY2012Dec 31, 2012$23.73M+7.6%
FY2011Dec 31, 2011$22.04M+4.9%
FY2010Dec 31, 2010$21.01M+19.6%
FY2009Dec 31, 2009$17.57M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$22.35M-6.9%
Q2 FY2026Jun 30, 2026$20.30M-5.9%
Q1 FY2026Mar 31, 2026$21.52M+4.8%
Q4 FY2025Dec 31, 2025$22.55M-13.4%
Q3 FY2025Sep 30, 2025$24.02M+13.2%
Q2 FY2025Jun 30, 2025$21.57M+2.2%
Q1 FY2025Mar 31, 2025$20.53M-6.9%
Q4 FY2024Dec 31, 2024$26.04M-2.9%
Q3 FY2024Sep 30, 2024$21.21M-12.6%
Q2 FY2024Jun 30, 2024$21.10M-8.8%
Q1 FY2024Mar 31, 2024$22.06M-3.6%
Q4 FY2023Dec 31, 2023$26.82M-5.6%
Q3 FY2023Sep 30, 2023$24.28M-3.5%
Q2 FY2023Jun 30, 2023$23.14M-12.2%
Q1 FY2023Mar 31, 2023$22.88M-8.6%
Q4 FY2022Dec 31, 2022$28.41M+29.5%
Q3 FY2022Sep 30, 2022$25.17M+29.2%
Q2 FY2022Jun 30, 2022$26.36M+44.7%
Q1 FY2022Mar 31, 2022$25.03M+55.7%
Q4 FY2021Dec 31, 2021$21.95M+41.8%
Q3 FY2021Sep 30, 2021$19.48M+28.2%
Q2 FY2021Jun 30, 2021$18.21M-12.6%
Q1 FY2021Mar 31, 2021$16.08M-13.8%
Q4 FY2020Dec 31, 2020$15.48M-18.9%
Q3 FY2020Sep 30, 2020$15.20M-8.6%
Q2 FY2020Jun 30, 2020$20.83M+23.6%
Q1 FY2020Mar 31, 2020$18.65M+16.0%
Q4 FY2019Dec 31, 2019$19.09M+12.4%
Q3 FY2019Sep 30, 2019$16.63M+5.2%
Q2 FY2019Jun 30, 2019$16.85M+8.6%
Q1 FY2019Mar 31, 2019$16.08M-2.8%
Q4 FY2018Dec 31, 2018$16.99M+6.9%
Q3 FY2018Sep 30, 2018$15.81M-3.7%
Q2 FY2018Jun 30, 2018$15.51M-8.3%
Q1 FY2018Mar 31, 2018$16.54M-1.6%
Q4 FY2017Dec 31, 2017$15.89M+6.6%
Q3 FY2017Sep 30, 2017$16.41M–
Q2 FY2017Jun 30, 2017$16.91M–
Q1 FY2017Mar 31, 2017$16.80M–
Q4 FY2016Dec 31, 2016$14.90M–

More Omnicell figures

See a number that looks wrong?